FPR1 contributes to atherosclerotic lesions by modulating the number of blood neutrophils under hypercholesterolemia (62) and exacerbates myocardial cell apoptosis and inflammation during ischemia-reperfusion through the MAPK signaling pathway (63). The gene discussed is FPR1; the disease is Hypercholesterolemia.